Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is -19.35% lower on its value in year-to-date trading and has touched a low of $6.76 and a high of $672.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TNXP stock was last observed hovering at around $28.00 in the last trading session, with the day’s loss setting it -1.4%.
Currently trading at $26.60, the stock is 35.72% and 40.48% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.83 million and changing -5.00% at the moment leaves the stock 21.31% off its SMA200. TNXP registered -95.45% loss for a year compared to 6-month gain of 88.39%.
The stock witnessed a 69.32% loss in the last 1 month and extending the period to 3 months gives it a 142.92%, and is 38.61% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.48% over the week and 9.79% over the month.
Tonix Pharmaceuticals Holding Corp (TNXP) has around 81 employees, a market worth around $194.84M and $10.04M in sales. Profit margin for the company is -1313.87%. Distance from 52-week low is 293.49% and -96.04% from its 52-week high. The company has generated returns on investments over the last 12 months (-73.00%).
The EPS is expected to grow by 92.98% this year.
Tonix Pharmaceuticals Holding Corp (TNXP) Top Institutional Holders
The shares outstanding are 7.32M, and float is at 7.32M with Short Float at 13.34%.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Activity
The most recent transaction is an insider purchase by LEDERMAN SETH, the company’s Chief Executive Officer. SEC filings show that LEDERMAN SETH bought 4,000 shares of the company’s common stock on May 15 ’25 at a price of $21.55 per share for a total of $86200.0. Following the purchase, the insider now owns 4005.0 shares.
